Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H -1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea

EU orphan designation number: EU/3/07/452   
Active ingredient: R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H -1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea
Indication: Treatment of gastric carcinoid
Sponsor: Trio Medicines Ltd
Pavilion View, 19 New Road, Brighton, East Sussex, BN1 1EY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/06/2007 Centralised Orphan - Designation EMEA/OD/014/07 (2007)3028 of 14/06/2007